SCHEMBL14070109

SCHEMBL14070109

CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)C3[C@@H](OC(=O)Nc3cccc(C(N)=O)c3)C[C@]12C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 7/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ PGR P06401 3/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ AR P10275 2/20 0.50
▸ CHRM1 P11229 2/20 0.50
▸ ADRA1A P35348 2/20 0.50
▸ TBXA2R P21731 1/20 0.50
▸ HSD11B2 P80365 6/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ NR3C2 P08235 4/20 0.38
▸ HSD11B1 P28845 2/20 0.38
▸ LMNA P02545 3/20 0.37
▸ CYP2C9 P11712 3/20 0.37
▸ HIF1A Q16665 3/20 0.37
▸ NR3C1 P04150 2/20 0.37
▸ TSHR P16473 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14020703 1.00 CYP3A4 (0.50) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020697 0.91 CYP3A4 (0.52) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020704 0.91 CYP3A4 (0.52) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020696 0.90 CYP3A4 (0.56) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020730 0.89 CYP3A4 (0.50) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020717 0.87 CYP3A4 (0.49) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020727 0.87 CYP3A4 (0.48) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020728 0.87 CYP3A4 (0.48) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14069927 0.86 CYP3A4 (0.47) CYP3A4ALDH1A1PGRCYP2C19AR
SCHEMBL14020699 0.85 CYP3A4 (0.54) CYP3A4ALDH1A1PGRCYP2C19AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008113851-A2 NOVEL C11 MODIFIED RETROSTEROIDS AS PROGESTERONE RECEPTOR MODULATOR COMPOUNDS SOLVAY PHARMACEUTICALS GMBH (DE) 2008-09-25 — — WO disclosed
Send feedback